Prostatype® – a new gene test for prostate cancer patients Scientific Publications White Papers Prostatype® Test System Provides Information on Overall Survival and Treatment Options for Patients With Newly Diagnosed Prostate Cancer. Conferences Validation of a 3-gene Signature and Development of an Authentic Cohort Database to Improve Overall Survival Prediction and Clinical Treatment Decision for Patients With Newly Diagnosed Prostate Cancer. Publications An Expression Signature at Diagnosis to Estimate Prostate Cancer Patients’ Overall Survival. Operator Dependent Choice of Prostate Cancer Biopsy Has Limited Impact on a Gene Signature Analysis for the Highly Expressed Genes IGFBP3 and F3 in Prostate Cancer Epithelial Cells. Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material. Posters An Expression Signature to Predict Overall and Cancer-Specific Survival of Prostate Cancer.